SeXX matters in immunity

Trends in Immunology

Volumn 35, Issue 3, 2014, Pages 97-104

  Markle, J G ^a   Fish, E N ^b,c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autoimmunity; Immune response; Infection; Sex; Vaccination

Indexed keywords

AUTOIMMUNITY; IMMUNE RESPONSE; INFECTION; SEX; VACCINATION;

ANIMALS; AUTOIMMUNITY; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; SEX CHARACTERISTICS; VACCINATION;

EID: 84894504760     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.10.006     Document Type: Review

References (85)

1. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2001, 2:777-780.
2. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 2008, 8:737-744.
3. Klein S.L., Poland G.A. Personalized vaccinology: one size and dose might not fit both sexes. Vaccine 2013, 31:2599-2600.
4. Klein S.L. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci. Biobehav. Rev. 2000, 24:627-638.
5. Guerra-Silveira F., Abad-Franch F. Sex bias in infectious disease epidemiology: patterns and processes. PLoS ONE 2013, 8:e62390.
6. Klein S.L., et al. The Xs and Y of immune responses to viral vaccines. Lancet Infect. Dis. 2010, 10:338-349.
7. Engler R.J., et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch. Intern. Med. 2008, 168:2405-2414.
8. Benn C.S., et al. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 2013, 34:431-439.
9. Whitacre C.C., et al. A gender gap in autoimmunity. Science 1999, 283:1277-1278.
10. Cooper G.S., Stroehla B.C. The epidemiology of autoimmune diseases. Autoimmun. Rev. 2003, 2:119-125.
11. Jacobson D.L., et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 1997, 84:223-243.
12. McCarty D.J., et al. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995, 38:1260-1270.
13. Rainey G.J., et al. Receptor-specific requirements for anthrax toxin delivery into cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13278-13283.
14. Butterworth M., et al. Influence of sex in immunoglobulin levels. Nature 1967, 214:1224-1225.
15. Cutolo M., et al. Sex hormones and rheumatoid arthritis. Autoimmun. Rev. 2002, 1:284-289.
16. Doran M.F., et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002, 46:625-631.
17. Weinshenker B.G. Natural history of multiple sclerosis. Ann. Neurol. 1994, 36(Suppl):S6-S11.
18. Young N.A., et al. Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus. Mol. Immunol. 2013, 54:23-31.
19. Makino S., et al. Effect of castration on the appearance of diabetes in NOD mouse. Jikken dobutsu. Exp. Anim. 1981, 30:137-140.
20. Fox H.S. Androgen treatment prevents diabetes in nonobese diabetic mice. J. Exp. Med. 1992, 175:1409-1412.
21. Bebo B.F., et al. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J. Neurosci. Res. 1998, 52:420-426.
22. Voskuhl R.R., et al. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann. Neurol. 1996, 39:724-733.
23. Ahmed S.A., Penhale W.J. The influence of testosterone on the development of autoimmune thyroiditis in thymectomized and irradiated rats. Clin. Exp. Immunol. 1982, 48:367-374.
24. Harbuz M.S., et al. A protective role for testosterone in adjuvant-induced arthritis. Br. J. Rheumatol. 1995, 34:1117-1122.
25. Roubinian J.R., et al. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 1978, 147:1568-1583.
26. Marttila S., et al. Transcriptional analysis reveals gender-specific changes in the aging of the human immune system. PLoS ONE 2013, 8:e66229.
27. Thomas P., et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
28. Mizukami Y. In vivo functions of GPR30/GPER-1, a membrane receptor for estrogen: from discovery to functions in vivo. Endocr. J. 2010, 57:101-107.
29. Garcia-Gomez E., et al. Role of sex steroid hormones in bacterial-host interactions. Biomed. Res. Int. 2013, 10.1155/2013/928290.
30. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006, 6:823-835.
31. Seillet C., et al. The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling. Blood 2012, 119:454-464.
32. Calippe B., et al. Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway. J. Immunol. 2008, 180:7980-7988.
33. Sandberg J.K., Ljunggren H.G. Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex. Trends Immunol. 2005, 26:347-349.
34. Sandberg J.K., et al. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur. J. Immunol. 2003, 33:588-596.
35. Montoya C.J., et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 2007, 122:1-14.
36. Gourdy P., et al. Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells. Blood 2005, 105:2415-2420.
37. Lotter H., et al. Testosterone increases susceptibility to amebic liver abscess in mice and mediates inhibition of IFNgamma secretion in natural killer T cells. PLoS One 2013, 8:e55694.
38. Maret A., et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur. J. Immunol. 2003, 33:512-521.
39. Zhang M.A., et al. Peroxisome proliferator-activated receptor (PPAR)alpha and -gamma regulate IFNgamma and IL-17A production by human T cells in a sex-specific way. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:9505-9510.
40. Bodhankar S., et al. Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+FoxP3+ regulatory T cells. Immunology 2012, 137:282-293.
41. Nicholson J.K., et al. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005, 3:431-438.
42. Yatsunenko T., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
43. Kisiela M., et al. Hydroxysteroid dehydrogenases (HSDs) in bacteria: a bioinformatic perspective. J. Steroid Biochem. Mol. Biol. 2012, 129:31-46.
44. Antunes L.C., et al. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob. Agents Chemother. 2011, 55:1494-1503.
45. Markle J.G., et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013, 339:1084-1088.
46. Yurkovetskiy L., et al. Gender bias in autoimmunity is influenced by microbiota. Immunity 2013, 39:400-412.
47. Bianchi I., et al. The X chromosome and immune associated genes. J. Autoimmun. 2012, 38:J187-J192.
48. Pisitkun P., et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006, 312:1669-1672.
49. Crow M.K., Wohlgemuth J. Microarray analysis of gene expression in lupus. Arthritis Res. Ther. 2003, 5:279-287.
50. Baechler E.C., et al. The emerging role of interferon in human systemic lupus erythematosus. Curr. Opin. Immunol. 2004, 16:801-807.
51. Banchereau J., et al. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004, 20:539-550.
52. Scofield R.H., et al. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum. 2008, 58:2511-2517.
53. Sawalha A.H., et al. Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J. Autoimmun. 2009, 33:31-34.
54. Cooney C.M., et al. 46,X,del(X)(q13) Turner's syndrome women with systemic lupus erythematosus in a pedigree multiplex for SLE. Genes Immun. 2009, 10:478-481.
55. Palaszynski K.M., et al. A yin-yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 2005, 146:3280-3285.
56. Smith-Bouvier D.L., et al. A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 2008, 205:1099-1108.
57. Arnold A.P., et al. What a difference an X or Y makes: sex chromosomes, gene dose, and epigenetics in sexual differentiation. Handb. Exp. Pharmacol. 2012, 214:67-88.
58. Edelmann M.N., Auger A.P. Epigenetic impact of simulated maternal grooming on estrogen receptor alpha within the developing amygdala. Brain Behav. Immun. 2011, 25:1299-1304.
59. Dai R., Ahmed S.A. microRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 2011, 157:163-179.
60. Blois S.M., et al. Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells. J. Reprod. Immunol. 2011, 88:86-92.
61. Somerset D.A., et al. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004, 112:38-43.
62. Aluvihare V.R., et al. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 2004, 5:266-271.
63. Elenkov I.J., et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab. 2001, 86:4933-4938.
64. Rowe J.H., et al. Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 2011, 10:54-64.
65. Thong Y.H., et al. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy. N. Engl. J. Med. 1973, 289:604-606.
66. Benshushan A., et al. Listeria infection during pregnancy: a 10 year experience. Isr. Med. Assoc. J. 2002, 4:776-780.
67. Montoya J.G., Remington J.S. Management of Toxoplasma gondii infection during pregnancy. Clin. Infect. Dis. 2008, 47:554-566.
68. Benki S., et al. Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. J. Infect. Dis. 2004, 189:2192-2201.
69. Neyrolles O., Quintana-Murci L. Sexual inequality in tuberculosis. PLoS Med. 2009, 6:e1000199.
70. Yamamoto Y., et al. Sex differences in the susceptibility of mice to infection induced by Mycobacterium intracellulare. Am. Rev. Respir. Dis. 1990, 142:430-433.
71. Tsuyuguchi K., et al. Effect of oestrogen on Mycobacterium avium complex pulmonary infection in mice. Clin. Exp. Immunol. 2001, 123:428-434.
72. Pathak S., et al. Age-dependent sex bias in clinical malarial disease in hypoendemic regions. PLoS ONE 2012, 7:e35592.
73. Wunderlich F., et al. Testosterone and other gonadal factor(s) restrict the efficacy of genes controlling resistance to Plasmodium chabaudi malaria. Parasite Immunol. 1991, 13:357-367.
74. Cernetich A., et al. Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection. Infect. Immun. 2006, 74:3190-3203.
75. Farzadegan H., et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998, 352:1510-1514.
76. Sterling T.R., et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N. Engl. J. Med. 2001, 344:720-725.
77. Napravnik S., et al. Gender difference in HIV RNA levels: a meta-analysis of published studies. J. Acquir. Immune Defic. Syndr. 2002, 31:11-19.
78. Jean C.M., et al. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg. Infect. Dis. 2007, 13:1918-1920.
79. Williams R.J., et al. An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am. J. Trop. Med. Hyg. 1997, 57:274-282.
80. Armien B., et al. High seroprevalence of hantavirus infection on the Azuero peninsula of Panama. Am. J. Trop. Med. Hyg. 2004, 70:682-687.
81. Mo R., et al. Estrogen regulates CCR gene expression and function in T lymphocytes. J. Immunol. 2005, 174:6023-6029.
82. Roivainen M., et al. Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 1994, 203:357-365.
83. Gavrilovskaya I.N., et al. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:7074-7079.
84. Wickham T.J., et al. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993, 73:309-319.
85. Van den Berg C.H., et al. Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLoS ONE 2011, 6:e27555.